BIRC5 and endometrioid tumor: Brunner and colleagues analyzed the expression of phosphohistone 3 (pHH3) and reported that patients with high grade endometrioid tumors and carcinomas expressed significantly higher levels of pHH3 and survivin than those with low-grade tumors.